In a woman with a complicated urinary tract infection caused by Escherichia coli who is allergic to trimethoprim‑sulfamethoxazole (Bactrim) and has already received doxycycline and nitrofurantoin (Macrobid), which antibiotic should be selected?

Fluoroquinolone (Ciprofloxacin or Levofloxacin) is the Antibiotic of Choice

For a woman with complicated UTI caused by E. coli who is allergic to Bactrim and has already failed doxycycline and Macrobid, you should prescribe a fluoroquinolone—specifically ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg once daily. 1

Why Fluoroquinolones Are Your Best Option

The 2024 European Association of Urology guidelines explicitly state that fluoroquinolones and cephalosporins are the only antimicrobial agents that can be recommended for oral empiric treatment in complicated UTI scenarios 1. Given your constraints:

• Macrobid (nitrofurantoin) is contraindicated for complicated UTIs—the FDA label explicitly states it's "indicated only for acute uncomplicated urinary tract infections" and warns that "nitrofurantoins lack the broader tissue distribution" needed for complicated infections 2
• Doxycycline has already been tried and presumably failed
• Bactrim is off the table due to allergy 3

This leaves fluoroquinolones as your primary oral option with proven efficacy for complicated UTI.

The Evidence Supporting Fluoroquinolones

Guideline Recommendations

The EAU guidelines provide specific dosing for complicated UTI 1:

• Oral therapy: Ciprofloxacin 500-750 mg twice daily for 7 days, or Levofloxacin 750 mg once daily for 5 days
• IV therapy (if hospitalization needed): Ciprofloxacin 400 mg twice daily or Levofloxacin 750 mg once daily

E. coli Specific Data

Research demonstrates fluoroquinolones maintain excellent activity against E. coli in complicated UTIs, with enoxacin (a quinolone) achieving 94.7% long-term eradication rates against E. coli in complicated UTI 4. While resistance patterns vary geographically, fluoroquinolones remain guideline-recommended first-line agents 1, 5.

Critical Caveats and Resistance Considerations

The 4-Step Decision Process

The 2025 IDSA guidelines recommend a systematic approach 6:

1. Assess severity of illness: If she's septic or severely ill, consider IV therapy initially
2. Evaluate resistance risk factors:
   • Recent fluoroquinolone use (within 3 months)
   • Recent hospitalization
   • Healthcare-associated infection
   • Known local resistance >10%
3. Patient-specific factors: History of tendon problems, QT prolongation, myasthenia gravis (fluoroquinolone contraindications)
4. Check local antibiogram if available

When Fluoroquinolones Won't Work

If local resistance exceeds 10% or she has recent fluoroquinolone exposure, you need parenteral alternatives 1:

• Ceftriaxone 1-2 g IV daily
• Cefepime 1-2 g IV twice daily
• Piperacillin-tazobactam 3.375-4.5 g IV three times daily
• Aminoglycosides (gentamicin 5 mg/kg daily or amikacin 15 mg/kg daily)

Alternative Oral Cephalosporins

If fluoroquinolones are contraindicated or resistance is documented, oral cephalosporins are your second choice 1:

• Cefpodoxime 200 mg twice daily for 10 days
• Ceftibuten 400 mg once daily for 10 days

However, the guidelines note that oral cephalosporins achieve "significantly lower blood and urinary concentrations than the intravenous route" 1, and recommend giving an initial IV dose of ceftriaxone before switching to oral therapy.

Common Pitfalls to Avoid

1. Don't use nitrofurantoin for complicated UTI—it lacks tissue penetration and the FDA specifically warns against this 2
2. Don't use fosfomycin—guidelines state there are "insufficient data regarding efficacy" for pyelonephritis/complicated UTI 1
3. Don't assume susceptibility—obtain urine culture before starting therapy and adjust based on results 1, 6
4. Don't underdose—use the higher end of dosing ranges for complicated infections

The Bottom Line Algorithm

Start with ciprofloxacin 750 mg twice daily orally unless:

• Local resistance >10% → switch to IV ceftriaxone or cefepime
• Recent fluoroquinolone use → switch to IV ceftriaxone or cefepime
• Fluoroquinolone contraindication → use oral cefpodoxime with initial IV ceftriaxone dose
• Severe sepsis/hemodynamic instability → hospitalize for IV therapy

Always obtain urine culture and adjust therapy based on susceptibilities within 48-72 hours 1, 6.